Kidney allograft fibrosis: what we learned from latest translational research studies
- PMID: 32193834
- DOI: 10.1007/s40620-020-00726-z
Kidney allograft fibrosis: what we learned from latest translational research studies
Abstract
To add new molecular and pathogenetic insights into the biological machinery associated to kidney allograft fibrosis is a major research target in nephrology and organ transplant translational medicine. Interstitial fibrosis associated to tubular atrophy (IF/TA) is, in fact, an inevitable and progressive process that occurs in almost every type of chronic allograft injury (particularly in grafts from expanded criteria donors) characterized by profound remodeling and excessive production/deposition of fibrillar extracellular matrix (ECM) with a great clinical impact. IF/TA is detectable in more than 50% of kidney allografts at 2 years. However, although well studied, the complete cellular/biological network associated with IF/TA is only partially evaluated. In the last few years, then, thanks to the introduction of new biomolecular technologies, inflammation in scarred/fibrotic parenchyma areas (recently acknowledged by the BANFF classification) has been recognized as a pivotal element able to accelerate the onset and development of the allograft chronic damage. Therefore, in this review, we focused on some new pathogenetic elements involved in graft fibrosis (including epithelial/endothelial to mesenchymal transition, oxidative stress, activation of Wnt and Hedgehog signaling pathways, fatty acids oxidation and cellular senescence) that, in our opinion, could become in future good candidates as potential biomarkers and therapeutic targets.
Keywords: Cellular senescence; Fatty acids oxidation; Interstitial fibrosis and tubular atrophy; Kidney fibrosis; Wnt pathway; hedgehog signaling pathways.
Similar articles
-
EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts.Clin Transplant. 2016 Mar;30(3):218-25. doi: 10.1111/ctr.12677. Epub 2016 Jan 30. Clin Transplant. 2016. PMID: 26659824
-
Diagnosis of interstitial fibrosis and tubular atrophy in kidney allograft: implementation of microRNAs.Iran J Kidney Dis. 2014 Jan;8(1):4-12. Iran J Kidney Dis. 2014. PMID: 24413714 Review.
-
Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.Kidney Int. 2017 Sep;92(3):729-742. doi: 10.1016/j.kint.2017.03.033. Epub 2017 May 26. Kidney Int. 2017. PMID: 28554738
-
Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.BMC Nephrol. 2015 Feb 13;16:19. doi: 10.1186/s12882-015-0011-y. BMC Nephrol. 2015. PMID: 25884518 Free PMC article.
-
Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?Curr Opin Nephrol Hypertens. 2014 May;23(3):245-50. doi: 10.1097/01.mnh.0000444811.26884.2d. Curr Opin Nephrol Hypertens. 2014. PMID: 24626060 Review.
Cited by
-
HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation.Front Immunol. 2023 Jul 21;14:1168848. doi: 10.3389/fimmu.2023.1168848. eCollection 2023. Front Immunol. 2023. PMID: 37545520 Free PMC article. Review.
-
Rictor/mTORC2 signalling contributes to renal vascular endothelial-to-mesenchymal transition and renal allograft interstitial fibrosis by regulating BNIP3-mediated mitophagy.Clin Transl Med. 2024 May;14(5):e1686. doi: 10.1002/ctm2.1686. Clin Transl Med. 2024. PMID: 38769658 Free PMC article.
-
Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants.Antioxidants (Basel). 2022 Apr 12;11(4):769. doi: 10.3390/antiox11040769. Antioxidants (Basel). 2022. PMID: 35453454 Free PMC article. Review.
-
Noninvasive Assessment of Interstitial Fibrosis and Tubular Atrophy in Renal Transplant by Combining Point-Shear Wave Elastography and Estimated Glomerular Filtration Rate.Diagnostics (Basel). 2021 Dec 23;12(1):18. doi: 10.3390/diagnostics12010018. Diagnostics (Basel). 2021. PMID: 35054186 Free PMC article.
-
Epigenetic modifications and the development of kidney graft fibrosis.Curr Opin Organ Transplant. 2021 Feb 1;26(1):1-9. doi: 10.1097/MOT.0000000000000839. Curr Opin Organ Transplant. 2021. PMID: 33315766 Free PMC article. Review.
References
-
- Liu Y (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69(2):213–217 - PubMed
-
- Melk A, Schmidt BM, Vongwiwatana A, Rayner DC, Halloran PF (2005) Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant 5(6):1375–1382 - PubMed
-
- Dimény E, Wahlberg J, Larsson E, Fellström B (1995) Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection? Clin Transplant 9(2):79–84 - PubMed
-
- Isoniemi HM, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Häyry P (1992) Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 41(1):155–160 - PubMed
-
- Serón D, Moreso F, Ramón JM et al (2000) Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 69(9):1849–1855 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous